Trial intelligence / Profile preview

TAST: Tacrolimus Sequential Therapy in Liver Transplantation

NCT00693524Phase 2Completed

Sponsor
Astellas Pharma
Start
Nov 2002
Primary completion
Mar 2004
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of tacrolimus + Wuzhi capsule in Liver transplant rejection, sponsored by Astellas Pharma. Started Nov 2002; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT00693524.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00693524.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call